10x Genomics (TXG) Leases (2020 - 2025)
Historic Leases for 10x Genomics (TXG) over the last 6 years, with Q4 2025 value amounting to $60.4 million.
- 10x Genomics' Leases rose 551.58% to $60.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $60.4 million, marking a year-over-year increase of 551.58%. This contributed to the annual value of $60.4 million for FY2025, which is 551.58% up from last year.
- As of Q4 2025, 10x Genomics' Leases stood at $60.4 million, which was up 551.58% from $63.6 million recorded in Q3 2025.
- 10x Genomics' 5-year Leases high stood at $75.7 million for Q1 2022, and its period low was $54.1 million during Q2 2021.
- Over the past 5 years, 10x Genomics' median Leases value was $62.8 million (recorded in 2024), while the average stood at $64.3 million.
- Per our database at Business Quant, 10x Genomics' Leases skyrocketed by 3565.82% in 2022 and then plummeted by 1590.62% in 2024.
- 10x Genomics' Leases (Quarter) stood at $60.9 million in 2021, then increased by 14.71% to $69.9 million in 2022, then fell by 6.47% to $65.4 million in 2023, then dropped by 12.35% to $57.3 million in 2024, then increased by 5.52% to $60.4 million in 2025.
- Its Leases was $60.4 million in Q4 2025, compared to $63.6 million in Q3 2025 and $62.7 million in Q2 2025.